ADMA Biologics revenue

ADMA Biologics revenue decreased from $22.8 million in 2017 to $17 million in 2018, a 25.4% decrease.

Annual Revenue ($)

ADMA Biologics revenue was $16.99 m in FY, 2018

Quarterly Revenue ($)

FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018
Revenue$3.07 m$5.92 m$7.18 m$10.66 m$22.76 m$16.99 m
Growth92.84%21.34%48.53%
Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019
Revenue$1.11 m$1.56 m$1.50 m$1.37 m$1.50 m$1.31 m$1.85 m$2.12 m$2.27 m$2.94 m$2.63 m$3.40 m$4.73 m$4.04 m$4.66 m$4.23 m$3.53 m$6.56 m

Annual Growth Rate (%)